Naprox Plus 500 mg+20 mg (Tablet (Delayed Release))
Unit Price: ৳ 15.00 (4 x 10: ৳ 600.00)
Strip Price: ৳ 150.00
Medicine Details
Category | Details |
---|---|
Generic | Naproxen sodium esomeprazole magnesium |
Company | Eskayef pharmaceuticals ltd |
Also available as |
Indications
- Relief of signs & symptoms of osteoarthritis
- Relief of signs & symptoms of rheumatoid arthritis
- Relief of signs & symptoms of ankylosing spondylitis
- Decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers
Pharmacology
- Consists of an immediate release Esomeprazole Magnesium layer & an enteric-coated Naproxen core
- Mechanism of action of Naproxen to inhibit prostaglandin synthesis
- Esomeprazole as a proton pump inhibitor that suppresses gastric acid secretion
Dosage
- Use lowest effective dose for the shortest duration consistent with individual patient treatment goals
- Dosage for adults: One tablet twice daily of either 375 mg naproxen/20 mg of esomeprazole or 500 mg naproxen/20 mg of esomeprazole
- Dosage for Juvenile Idiopathic Arthritis in Adolescent Patients 12 Years of Age & Older
Administration
- Do not split, chew, crush or dissolve the tablet
- To be taken at least 30 minutes before meals
Interaction
- Concomitant use of NSAIDs may reduce the antihypertensive effect of ACE inhibitors, diuretics & beta-blockers
- Concomitant use of this tablet and warfarin may result in an increased risk of a bleeding complication
- Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability
- Administration of Naproxen & Esomeprazole together with high-fat food in healthy volunteers does not affect the extent of absorption of naproxen
Contraindications
- Known hypersensitivity to any component of this tablet or substituted benzimidazoles
- History of asthmay urticaria or other allergic-type reactions after taking aspirin or other NSAIDs
- Use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
Side Effects
- Decrease in the occurrence of gastric ulcers and NSAID associated upper gastrointestinal adverse events
- Gastrointestinal side effects from Naproxen
- Increased risk of arterial thrombotic events with use of coxibs and some NSAIDs
Pregnancy & Lactation
- Naproxen and Esomeprazole tablet should not be given during the first and second trimester of pregnancy unless the potential benefit to the patient outweighs the potential risk to the foetus
- Naproxen and Esomeprazole tablet is contraindicated during the third trimester of pregnancy
- Naproxen and Esomeprazole tablet should not be used during breastfeeding
Precautions & Warnings
- The combination of Naproxen and Esomeprazole tablet and NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided
- Use the lowest effective dose for the shortest duration necessary to control symptoms
- Risk-factors to develop NSAID related gastro-intestinal complications
Use in Special Populations
- Use caution when high doses are required & some adjustment of dosage may be required in elderly patients
- Naproxen-containing products are not recommended for use in patients with moderate to severe or severe renal impairment
- Monitor patients with mild to moderate hepatic impairment closely
Overdose Effects
- Symptoms related to Naproxen overdose
- Symptoms related to esomeprazole overdose
- Management of overdose
Therapeutic Class
- Drugs for Osteoarthritis
- Drugs used for Rheumatoid Arthritis
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Storage Conditions
- Store at temperature of below 30°C
- Protect from light & moisture
- Keep out of reach of children
Related Brands
- Naproxen Plus 375 mg+20 mg (Tablet (Delayed Release)) - zenith-pharmaceuticals-ltd
- Naproxen Plus 500 mg+20 mg (Tablet (Delayed Release)) - zenith-pharmaceuticals-ltd
- Napsec 375 mg+20 mg (Tablet (Delayed Release)) - drug-international-ltd
- Napsec 500 mg+20 mg (Tablet (Delayed Release)) - drug-international-ltd
- Napxon 375 mg+20 mg (Tablet (Delayed Release)) - ziska-pharmaceuticals-ltd